Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights

Go back to Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights

OptiNose (OPTN) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY24 Guidance

November 12, 2024 7:09 AM EST

OptiNose (NASDAQ: OPTN) reported Q3 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $22.95 million.

The Company expects XHANCE net revenues for the full year of 2024 to be between $75.0 to $79.0 million.... More